Dr. Emad Kandil's Insightful Visit to Guangzhou: A Step Forward in MWA Collaboration

Dr. Emad Kandil recently embarked on a productive three-day visit to Guangzhou, China, where he explored the advancements in microwave ablation (MWA) procedures. His visit included stops at Baird Medical (Baird), Sun Yat-sen University Cancer Center (one of China's leading oncology institutions), and Guangzhou First People's Hospital.

Understanding MWA Procedures in China

Dr. Kandil's primary focus was to gain a deeper understanding of MWA procedures in China and to learn more about Baird, a pioneer in the field of thyroid MWA treatment. His engagement with Chinese surgeons and ultrasound doctors was both close and effective, allowing for a meaningful exchange of knowledge and practices. Dr. Kandil was particularly impressed by the efficiency and skill demonstrated in the Chinese medical community, noting the high turnover rate and large patient base that drive innovation and excellence in treatment methods.

Dr. Kandil with experts from Sun Yat-sen University Cancer Center

Engagement and Knowledge Exchange

During his visit, Dr. Kandil observed nine MWA surgeries, providing him with valuable insights into the local practices and techniques. These observations were instrumental in understanding the nuances and specific approaches adopted by Chinese medical professionals. At Sun Yat-sen University Cancer Center, Dr. Kandil initially expressed concern about the "dullness" of the MWA needle tip, which he believed might hinder its ability to puncture the skin effectively. However, he was impressed to learn that the Chinese doctors use a sharper, harder needle first to make the initial puncture, followed by the MWA needle. The MWA needle, designed for water circulation, has a hollow structure, enhancing the efficiency and safety of the procedure. This innovative approach reassured Dr. Kandil about the effectiveness of the equipment and techniques used.

Dr. Kandil watching procedure done by Dr. Xiaoqing Pei from Sun Yat-sen University Cancer Center

After-procedure discussion

Baird's minimally invasive needle

Additionally, Dr. Kandil delivered an enlightening lecture to the doctors at Guangzhou First People's Hospital, sharing his expertise and experiences. The lecture was well-received, sparking engaging discussions on best practices and the future of MWA technology. 

President of Guangzhou First People's Hospital (left), Dr. Kandil (middle), and Dr. Xing (right)

Building Confidence and Future Collaborations

Dr. Kandil expressed great confidence in the potential for expanding MWA cases and emphasized the importance of facilitating clinical research progress in the U.S. He is particularly interested in multi-institutional studies involving MWA, highlighting his commitment to advancing this innovative treatment. Dr. Kandil discussed the possibility of collaborative studies that could bridge the knowledge gap between the U.S. and China, fostering a global approach to improving patient outcomes.

Dr. Feng Han and Dr. Kandil 
Commitment to Innovation

Dr. Kandil's visit underscored Baird Medical's role as a leading innovator in thyroid MWA treatment. By engaging with top medical institutions and professionals in China, Baird Medical continues to solidify its reputation as a key player in the medical field. Dr. Kandil’s enthusiasm and dedication to improving thyroid MWA treatment are expected to drive further advancements and research in this area, benefiting patients worldwide.

Conclusion

Overall, Dr. Kandil's visit to Guangzhou was a significant step towards strengthening international collaboration in the field of MWA. His interactions with Chinese surgeons and ultrasound doctors, combined with his observations and lecture, have laid the groundwork for future partnerships and research initiatives. Dr. Kandil looks forward to continued collaboration and the shared goal of advancing thyroid MWA treatment globally.